Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
24 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Cardiovascular Research Center Aalst from Aalst, company number BE0470425452, closed financial year 2025 with a result of € -228,231 after tax. For that financial year Cardiovascular Research Center Aalst recorded a gross margin of € 173,775 and equity of € 793,170. Compared with financial year 2024, the result moved from € 73,821 to € -228,231. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.
€ 793,170
▼ 22% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -228,231
▼ still € 73,821 profit in 2024
Profit after tax over the fiscal year.
€ 303,577
▼ 27% vs 2024
Cash and bank balances on the last day of the fiscal year.
People and assets in 2025
€ 451,929
▲ 26% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 243,919
▼ 37% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 59,157
▼ 21% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -486,817 | € 213,473 | € 477,121 | € 173,775 | ▼ 64% |
| Profit after taxes | € -833,155 | € -56,199 | € 73,821 | € -228,231 | ▼ € 302,053 |
| Equity | € 1,003,779 | € 947,580 | € 1,021,402 | € 793,170 | ▼ 22% |
| Total debts | € 301,333 | € 322,418 | € 471,833 | € 329,742 | ▼ 30% |
| Cash | € 272,570 | € 97,376 | € 413,487 | € 303,577 | ▼ 27% |
| Retained profit | € 1,003,779 | € 947,580 | € 1,021,402 | € 793,170 | ▼ 22% |
| Balance sheet total | € 1,305,112 | € 1,269,998 | € 1,493,235 | € 1,122,912 | ▼ 25% |
| Employees (FTE) | 6.7 | 7 | - | - |
Key figures of Cardiovascular Research Center Aalst, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Cardiovascular Research Center Aalst?
What happened at Cardiovascular Research Center Aalst in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 228,231 (▼ € 302,053 vs 2024). Source: NBB ↗
- Eric Wyffels became a director. NBB
- Ward Heggermont became a director. NBB
- Peter Peytchev became a director. NBB
- Tom De Potter became a director. NBB
- New establishment in Aalst. KBO
- Jozef Bartunek became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 833,155 loss in 2022 to € 228,231 loss in 2025.
Paid € 19,423 in corporate taxes since 2022.
Best year ever: 2024, with € 73,821 profit.
On average € 30,500 of value added per employee in 2023.
Management
Behind Cardiovascular Research Center Aalst are Peter Peytchev, Eric Wyffels, Jozef Bartunek, Ward Heggermont and Tom De Potter. Peter Peytchev is also behind CARDIAC RESEARCH INSTITUTE. Eric Wyffels is also behind DR. E. WYFFELS. Jozef Bartunek is also behind CARDIAC RESEARCH INSTITUTE, CoreAalst and DICENTRA. Ward Heggermont is also behind CARDIAC RESEARCH INSTITUTE, Dr. W. Heggermont, cardiologie and CoreAalst.
Directors
According to the 2025 annual accounts
since 2018
since 2019
since 2002
Ward Heggermont
Director
Also active at: CARDIAC RESEARCH INSTITUTE, Dr. W. Heggermont, cardiologie, CoreAalst
since 2018
Tom De Potter
Director
since 2018
Establishments
Establishment units
Physical locations of this company
Moorselbaan 164
9300 Aalst
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 24 companies are registered at this address.
All companies at this address →Onze-Lieve-Vrouwziekenhuis
€ 0 revenue · 2025
Vakantiedialyse
NEUROCHIRURGIE
OLV RESEARCH UNIT
€ -57,102 gross margin · 2022
CARDIAC RESEARCH INSTITUTE same network
€ 454,497 gross margin · 2025
+19 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0470.425.452
- VAT number
- BE 0470.425.452
- Registered office
- Moorselbaan 164, 9300 Aalst
- Names & denominations
- Cardiovascular Research Center Aalst · CVRCA
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 9 July 1999
- Peppol
- Active · Active since 6 Oct 2026
- Activities · NACE
Overige zakelijke dienstverlening, neg